Cross Country Healthcare, Inc.
Cross Country Healthcare, Inc. Fundamental Analysis
Cross Country Healthcare, Inc. (CCRN) shows weak financial fundamentals with a PE ratio of -18.50, profit margin of -1.39%, and ROE of -3.78%. The company generates $1.1B in annual revenue with weak year-over-year growth of -33.46%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of -6.2/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze CCRN's fundamental strength across five key dimensions:
Efficiency Score
WeakCCRN struggles to generate sufficient returns from assets.
Valuation Score
ExcellentCCRN trades at attractive valuation levels.
Growth Score
WeakCCRN faces weak or negative growth trends.
Financial Health Score
ExcellentCCRN maintains a strong and stable balance sheet.
Profitability Score
WeakCCRN struggles to sustain strong margins.
Key Financial Metrics
Is CCRN Expensive or Cheap?
P/E Ratio
CCRN trades at -18.50 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, CCRN's PEG of 0.21 indicates potential undervaluation.
Price to Book
The market values Cross Country Healthcare, Inc. at 0.71 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 61.49 times EBITDA. This signals the market has high growth expectations.
How Well Does CCRN Make Money?
Net Profit Margin
For every $100 in sales, Cross Country Healthcare, Inc. keeps $-1.39 as profit after all expenses.
Operating Margin
Core operations generate -1.44 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $-3.78 in profit for every $100 of shareholder equity.
ROA
Cross Country Healthcare, Inc. generates $-2.91 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Cross Country Healthcare, Inc. generates limited operating cash flow of $54.64M, signaling weaker underlying cash strength.
Free Cash Flow
Cross Country Healthcare, Inc. produces free cash flow of $46.00M, offering steady but limited capital for shareholder returns and expansion.
FCF Per Share
Each share generates $1.40 in free cash annually.
FCF Yield
CCRN converts 15.58% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
-18.50
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.21
vs 25 benchmark
P/B Ratio
Price to book value ratio
0.71
vs 25 benchmark
P/S Ratio
Price to sales ratio
0.26
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.005
vs 25 benchmark
Current Ratio
Current assets to current liabilities
3.45
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
-0.04
vs 25 benchmark
ROA
Return on assets percentage
-0.03
vs 25 benchmark
ROCE
Return on capital employed
-0.04
vs 25 benchmark
How CCRN Stacks Against Its Sector Peers
| Metric | CCRN Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | -18.50 | 29.45 | Better (Cheaper) |
| ROE | -3.78% | 779.00% | Weak |
| Net Margin | -1.39% | -24936.00% (disorted) | Weak |
| Debt/Equity | 0.01 | 0.26 | Strong (Low Leverage) |
| Current Ratio | 3.45 | 4.65 | Strong Liquidity |
| ROA | -2.91% | -19344.00% (disorted) | Weak |
CCRN outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Cross Country Healthcare, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
75.39%
Industry Style: Defensive, Growth, Innovation
High GrowthEPS CAGR
72.08%
Industry Style: Defensive, Growth, Innovation
High GrowthFCF CAGR
2225.55%
Industry Style: Defensive, Growth, Innovation
High Growth